Latest Breaking News On - Group is not - Page 1 : comparemela.com

Highlights AIM’s Significant Momentum and Ongoing Achievement of Clinical and Regulatory Milestones Urges Shareholders to Protect AIM’s Progress by Voting for the Company’s Board of Directors.

United statesThomask equelsMichaelj xirinachsFranzn tudorAstrazeneca imfinziWilliamm mitchellRobertl chioiniNancyk bryanStewartl appelrouthTedd kellnerEarly access programAmerican journal of cancer researchCompany on twitterGroup is notIndevus pharmaceuticalsUniversity of nebraska